You have no items in your cart.
Orladeyo Now Reimbursable in Japan via National Health Insurance
Angioedema News
Japan’s National Health Insurance System (NHI) has approved the addition of Orladeyo (berotralstat), an oral preventive treatment for hereditary angioedema (HAE) attacks, to its drug price list. This means that ... Read more